Management Report
Subsequent Events
Since June 30, 2008, no events of special significance have occurred that we expect to have a material impact on the financial position or results of operations of the Bayer Group.
11 of 11
- Home
- Key Data
- Bayer-Stock
- Management Report
- Financial Statements
- Focus
- News
Overview- Protecting crops against black stem rust
- YAZ registered in Europe
- Werner Wenning receives McCloy Award
- Movento insecticide approved in the U.S. and Canada
- Rivaroxaban again shows superior efficacy to enoxaparin
- Brazil – a growing market for Bayer
- Bayer receives environmental award
- Medicines from tobacco plants
- In the fast lane with BayVision
- Phase II data: Nexavar effective against further types of cancer
- Rice research laboratory opened in Singapore
- New study with VEGF Trap-Eye: Shedding light on blindness
- Makrofol ID used in British driver’s licenses
- Services
- Overview of Sales, Earnings and Financial Position
- Future Perspectives
- Performance by Subgroup and Segment
- Calculation of EBIT(DA) Before Special Items
- Liquidity and Capital Resources
- Employees
- Opportunities and Risks
Subsequent Events
Bayer Links- Bayer Global
- Bayer HealthCare
- Bayer CropScience
- Bayer MaterialScience
- Bayer Business Services
- Bayer Technology Services
- Currenta
- Special Interest
Investor Relations- Press
- Jobs and Career
- Culture
Bookmark this page
E-mail this page
Search
Advanced Search
Links
Services
Calendar
Info
